BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 27342697)

  • 1. Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016).
    Mancini GB; Baker S; Bergeron J; Fitchett D; Frohlich J; Genest J; Gupta M; Hegele RA; Ng D; Pearson GJ; Pope J; Tashakkor AY
    Can J Cardiol; 2016 Jul; 32(7 Suppl):S35-65. PubMed ID: 27342697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update.
    Mancini GB; Tashakkor AY; Baker S; Bergeron J; Fitchett D; Frohlich J; Genest J; Gupta M; Hegele RA; Ng DS; Pearson GJ; Pope J
    Can J Cardiol; 2013 Dec; 29(12):1553-68. PubMed ID: 24267801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin intolerance - a question of definition.
    Algharably EA; Filler I; Rosenfeld S; Grabowski K; Kreutz R
    Expert Opin Drug Saf; 2017 Jan; 16(1):55-63. PubMed ID: 27645111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert opinion: the therapeutic challenges faced by statin intolerance.
    Patel J; Martin SS; Banach M
    Expert Opin Pharmacother; 2016 Aug; 17(11):1497-507. PubMed ID: 27254275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.
    Banach M; Rizzo M; Toth PP; Farnier M; Davidson MH; Al-Rasadi K; Aronow WS; Athyros V; Djuric DM; Ezhov MV; Greenfield RS; Hovingh GK; Kostner K; Serban C; Lighezan D; Fras Z; Moriarty PM; Muntner P; Goudev A; Ceska R; Nicholls SJ; Broncel M; Nikolic D; Pella D; Puri R; Rysz J; Wong ND; Bajnok L; Jones SR; Ray KK; Mikhailidis DP
    Expert Opin Drug Saf; 2015 Jun; 14(6):935-55. PubMed ID: 25907232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.
    Mohassel P; Mammen AL
    Muscle Nerve; 2013 Oct; 48(4):477-83. PubMed ID: 23519993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Statin intolerance and associated muscular dysfunctions].
    Boulanger-Piette A; Bergeron J; Desgreniers J; Côté-Levesque M; Brassard D; Joanisse DR; Frenette J
    Med Sci (Paris); 2015 Dec; 31(12):1109-14. PubMed ID: 26672664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Statin intolerance].
    Graversen CB; Larsen ML; Schmidt EB
    Ugeskr Laeger; 2015 Aug; 177(36):. PubMed ID: 26324293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment by the Statin Intolerance Panel: 2014 update.
    Guyton JR; Bays HE; Grundy SM; Jacobson TA; The National Lipid Association Statin Intolerance Panel
    J Clin Lipidol; 2014; 8(3 Suppl):S72-81. PubMed ID: 24793444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin intolerance.
    Ahmad Z
    Am J Cardiol; 2014 May; 113(10):1765-71. PubMed ID: 24792743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin-associated necrotizing autoimmune myopathy.
    Fernandes GH; Zanoteli E; Shinjo SK
    Mod Rheumatol; 2014 Sep; 24(5):862-4. PubMed ID: 24517559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing Cholesterol Treatment in Patients With Muscle Complaints.
    Rosenson RS; Baker S; Banach M; Borow KM; Braun LT; Bruckert E; Brunham LR; Catapano AL; Elam MB; Mancini GBJ; Moriarty PM; Morris PB; Muntner P; Ray KK; Stroes ES; Taylor BA; Taylor VH; Watts GF; Thompson PD
    J Am Coll Cardiol; 2017 Sep; 70(10):1290-1301. PubMed ID: 28859793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference.
    Mancini GB; Baker S; Bergeron J; Fitchett D; Frohlich J; Genest J; Gupta M; Hegele RA; Ng D; Pope J
    Can J Cardiol; 2011; 27(5):635-62. PubMed ID: 21963058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects.
    Li JJ; Liu HH; Wu NQ; Yeo KK; Tan K; Ako J; Krittayaphong R; Tan RS; Aylward PE; Baek SH; Dalal J; Fong AYY; Li YH; O'Brien RC; Lim TSE; Koh SYN; Scherer DJ; Tada H; Kang V; Butters J; Nicholls SJ
    Expert Opin Drug Metab Toxicol; 2020 Sep; 16(9):837-851. PubMed ID: 32729743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin-Associated Side Effects.
    Thompson PD; Panza G; Zaleski A; Taylor B
    J Am Coll Cardiol; 2016 May; 67(20):2395-2410. PubMed ID: 27199064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin Intolerance: A Review and Update.
    Tsushima Y; Hatipoglu B
    Endocr Pract; 2023 Jul; 29(7):566-571. PubMed ID: 36958647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin associated muscle symptoms (SAMS): strategies for prevention, assessment and management.
    Iatan I; Mancini GBJ; Yeoh E; Hegele RA
    Expert Rev Cardiovasc Ther; 2023 Jun; 21(6):423-435. PubMed ID: 37212306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STATIN-ASSOCIATED INTOLERANCE AND ITS PREVENTION.
    Karsanidze A; Antelava N; Gorgasledze N; Ghonghadze M; Okudzhava M; Pachkoria K
    Georgian Med News; 2018 Jun; (279):155-161. PubMed ID: 30035739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin-induced myopathy: a review and update.
    Abd TT; Jacobson TA
    Expert Opin Drug Saf; 2011 May; 10(3):373-87. PubMed ID: 21342078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assessment by the Statin Muscle Safety Task Force: 2014 update.
    Rosenson RS; Baker SK; Jacobson TA; Kopecky SL; Parker BA; The National Lipid Association's Muscle Safety Expert Panel
    J Clin Lipidol; 2014; 8(3 Suppl):S58-71. PubMed ID: 24793443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.